These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 7885047
1. Childhood acute lymphoblastic leukemia (ALL): sister chromatid exchange (SCE) frequency and lymphocyte subpopulations during therapy. Mertens R, Rubbert F, Büssing A. Leukemia; 1995 Mar; 9(3):501-5. PubMed ID: 7885047 [Abstract] [Full Text] [Related]
2. [SCE rate and lymphocyte differentiation in children with acute lymphoblastic leukemia and SCE rates of leukemia patients in long-term remission]. Mertens R, Büssing A, Rubbert F, Lassay L, Heimann G. Klin Padiatr; 1996 Mar; 208(2):73-6. PubMed ID: 8901186 [Abstract] [Full Text] [Related]
3. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Schlieben S, Borkhardt A, Reinisch I, Ritterbach J, Janssen JW, Ratei R, Schrappe M, Repp R, Zimmermann M, Kabisch H, Janka-Schaub G, Bartram CR, Ludwig WD, Riehm H, Lampert F, Harbott J. Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652 [Abstract] [Full Text] [Related]
4. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)? Jakab Z, Balogh E, Karászi E, Kappelmayer J, Kiss C, Oláh E. Med Pediatr Oncol; 2002 Jul; 39(1):63-5. PubMed ID: 12116086 [No Abstract] [Full Text] [Related]
5. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G. Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576 [Abstract] [Full Text] [Related]
6. [Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections]. Luczyński W, Stasiak-Barmuta A, Krawczuk-Rybak M, Zak J. Wiad Lek; 2004 Sep; 57(7-8):337-42. PubMed ID: 15631188 [Abstract] [Full Text] [Related]
16. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors. Ishii E, Eguchi H, Matsuzaki A, Koga H, Yanai F, Kuroda H, Kawakami K, Ayukawa H, Akiyoshi K, Kamizono J, Tamai Y, Kinukawa N, Okamura J. Med Pediatr Oncol; 2001 Jul 27; 37(1):10-9. PubMed ID: 11466717 [Abstract] [Full Text] [Related]
17. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia. Tantawy AA, El-Bostany EA, Adly AA, Abou El Asrar M, El-Ghouroury EA, Abdulghaffar EE. Blood Coagul Fibrinolysis; 2010 Jan 27; 21(1):28-34. PubMed ID: 19923983 [Abstract] [Full Text] [Related]
18. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95. Hinze L, Möricke A, Zimmermann M, Junk S, Cario G, Dagdan E, Kratz CP, Conter V, Schrappe M, Stanulla M. Leukemia; 2017 Aug 27; 31(8):1840-1842. PubMed ID: 28529312 [No Abstract] [Full Text] [Related]